WEEK 1: Acute Respiratory Infections and pneumonias Flashcards

1
Q

Outline the 4 Upper airway defenses.

A
  1. Nasal hairs -trap large air particles,
  2. Ciliated epithelium clear smaller particles
  3. Cough reflex -expectoration,
  4. Larynx –sphincter -closes to protect the airway during swallowing and vomiting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The sterility, structure and function of the lower airways are maintained by the innate and adaptive immune responses.

Outline the Lower airway defenses.

A
  1. Airway mucus; antimicrobial peptides (such as defensins, IgA and lysozyme), anti-proteinases and antioxidants
  2. opsonization and killing of bacteria and the regulation of the proteolytic enzymes secreted by inflammatory cells
  3. Muco-ciliary escalator
  4. Macrophages engulf microbes, organic dusts and other particulate matter.
  5. Pulmonary circulation contains a marginated pool of neutrophils -recruited in response to bacterial infection.
  6. Adaptive immunity is characterized by the specificity of the response and the development of memory.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define OPPORTUNISTIC PATHOGENS.

A

Usually benign but have the ability to cause disease in an immunocompromised host (e.g., patients with AIDS, chemotherapy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Outline examples of opportunistic pathogens.

A

Examples ofopportunistic infectionsinclude:
-Oral candidiasis
-Pneumocystis Jirovecci Pneumonia
-Cytomegalovirus
-Cryptococcal Meningitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define COMMENSAL MICROORGANISMS

A

Microorganisms (e.g., bacteria, fungi) living on or within humans that do not harm the host under normal circumstances and may even be beneficial (e.g., by inhibiting the growth of pathogens or helping with digestion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Give examples of commensal microorganisms and where they are found.

A

Examples;

Normal nasal flora:Staphylococcus epidermidis

Normal oropharyngeal flora:Viridans group streptococci

Normal lung flora:Neisseriacatarrhalis,alpha-hemolyticstreptococci,staphylococci, non-pathogeniccorynebacteria,Candida albicans, Bacteroides, haemophilus influenzae

Normal flora ofdental plaques:Streptococcus mutans

Normal gut flora:Escherichia coliandBacteroides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define LOWER RESPIRATORY TRACT INFECTIONS (LRTI) and give examples.

A

Infections (usually bacterial or viral) involving the lower respiratory tract, which may affect the bronchi, lung parenchyma, or both.

Examples include pneumonia, bronchitis, lung abscess.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is bronchitis?

State its main cause.

State 6 signs and symptoms.

Outline differential diagnoses.

Describe thew management.

Outline complications that may come about.

A

Inflammationof the bronchi

Often follows an upper respiratory tract infection (URTI) and, in >90% of cases, the cause is viral.

May manifest with cough, dyspnea, chest pain, runny nose, headache, and malaise.

**The cough is often productive and may persist for2–3 weeksand is usually self-limiting.

Clinical diagnosis; clinical symptoms and auscultationfindings (Clear or wheeze)

Further diagnostic testing is not routinely necessary.

Differential diagnoses; asthma, acute exacerbation of COPD, and pneumonia

Management consists of adequate hydration and symptomatic relief.

Treatment with antibiotics generally not indicated.

Complications include Respiratory Failure, Secondary bacterial infections (especially pneumonia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Define pneumonia.

How is it transmitted?

State the most common bacterial pathogens.

Describe the classification of pneumonia.

A

Inflammationof the alveolar space and/or the interstitial tissue of the lungs.

Transmission: aspirationof airborne pathogens (mainly bacteria, but also virusesand fungi)

The most common bacterial pathogens include Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus.

Causative pathogens can be inferred based on patient age, immune status and where the infection was acquired. Definitively identified on sputum/blood culture

Classified based on clinical features as either typical or atypical.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Compare typical vs atypical pneumonia.

A

Typical Pneumonia:

  1. Bacterial Infections:
    Most cases of typical pneumonia are caused by bacteria.
    The most common bacterial pathogens include Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus.
  2. Abrupt Onset: Typical pneumonia often has a sudden and more severe onset of symptoms.
  3. This includes a high fever, chills, productive cough with discolored sputum, chest pain, and difficulty breathing.
  4. Consolidation of Lung Tissue: Bacterial pneumonia typically leads to consolidation of lung tissue, meaning that the alveoli are filled with inflammatory cells and fluid, reducing the lung’s ability to exchange oxygen and carbon dioxide.
  5. Response to Antibiotics: Treatment for typical bacterial pneumonia involves antibiotics. The choice of antibiotic depends on the specific bacteria causing the infection.

Atypical Pneumonia:

  1. Various Pathogens:
    Atypical pneumonia is caused by pathogens such as Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella pneumophila.

These are often intracellular bacteria a
and do not respond as well to traditional antibiotics.

  1. Gradual Onset: Symptoms of atypical pneumonia tend to develop more gradually and are often less severe compared to typical pneumonia.
  2. Common symptoms include a persistent dry cough, headache, fatigue, and sometimes gastrointestinal symptoms.
  3. Patchy Infiltrates in Lungs: Unlike the consolidated appearance seen in typical pneumonia, atypical pneumonia often leads to more diffuse and patchy infiltrates in the lungs.
  4. Macrolide or Tetracycline Treatment: Atypical pneumonia is often treated with macrolide antibiotics (such as azithromycin) or tetracyclines (such as doxycycline).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the diagnosis and treatment of pneumonia.

A

Diagnostics include blood tests for inflammatory markers,radiographic imaging and pathogen detection in blood, urine, or sputum samples.

Inflammatory markers: C-reactive protein, Procalcitonin, ESR

Management consists of empiric antibiotic treatmentand supportive measures (e.g., oxygen administration,IV Fluids).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Outline PNEUMONIA: RISK FACTORS.

A
  1. Immunosuppression: HIV, Chemotherapy, malnutrition, diabetes, alcoholism
  2. Chronic diseases: Pre-existing cardiopulmonary diseases, acquired or congenital lung abnormalities.
  3. Impaired airway protection: Smoking, altered consciousness
  4. Environmental factors: Toxins, crowded living arrangement, endemic areas, zoonotic exposures, contaminated water systems.
  5. Surgical procedures: Chest surgery, Upper abdominal surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Outline the routes of infection for pneumonia.

A

Routes of infection

Most common:micro-aspiration(droplet infection) ofairborne pathogensor oropharyngeal secretions

Aspirationofgastric acid(aspiration pneumonitis), food, or liquids

Hematogenous dissemination (uncommon)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the pathogenesis of pneumonia.

A

Pathogenesis
1. Failure of protective pulmonary mechanisms(e.g.,cough reflex,mucociliary clearance,alveolar macrophages)

  1. Infiltration of thepulmonary parenchymaby thepathogen→interstitialand alveolar inflammation.
  2. Impairedalveolar ventilation→ventilation/perfusion(V/Q) mismatchwith intrapulmonary shunting (right to left)
  3. Hypoxiadue to increasedalveolar-arterial oxygen gradient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DESCRIBE PNEUMONIA CLASSIFICATION BY LOCATION ACQUIRED.

Define community acquired pneumonia and outline the causative pathogens.

Describe Hospital acquired pneumonia and outline the causative pathogens.

Describe Ventilator associated pneumoniae.

A

Develops in the outpatient setting or within 48 hours of admission into the hospital.

Develops at least 48 hours after admission into the hospital.
-Streptococcus aureus, Staphylococcus pneumonia, Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter spp

-Characterized by increased exposure to Multi drug resistant organisms.

Healthcare-associated pneumonia(HCAP): pneumonia acquired inhealthcare facilities(e.g., hospital, nursing homes, thehemodialysiscenters, and outpatient clinics); this terminology is no longer recommended but is included for historical purposes.

Develops more than 48 hours after endotracheal intubation or within 48 hours of extubating.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the 4 pneumonias according to Area of lung affected by the pathology.

A

Lobar pneumonia: pneumonia affecting one lobe of a lung.

Bronchial pneumonia: pneumonia affecting the tissue around the bronchi and/or bronchioles.

Interstitial pneumonia: pneumonia affecting the tissue between the alveoli.

Cryptogenic organizing pneumonia (formerly known as bronchiolitis obliterans organizing pneumonia): a noninfectious pneumonia of unknown etiology characterized by the involvement of the bronchioles, alveoli, and surrounding tissue.

17
Q

PNEUMONIA: PATHOLOGICAL CLASSIFICATION.

  1. -Radiological and pathological term referring to a Classical/Typical type of Pneumonia, characterized by homogeneous consolidation of one or more lung lobes, often with associated pleural inflammation.

-Characterized by inflammatoryintra-alveolarexudate, resulting in consolidation
Infection spreads to adjacent alveoli until constrained by anatomical barriers between segment or lobes of the lungs.

  1. *Refers to more patchy alveolar consolidation associated with bronchial and bronchiolar inflammation

*Characterized by inflammatory infiltrates that fill thebronchiolesand the adjacentalveoli(patchy distribution)

*Usually involves the lower lobes or right middle lobe and affects≥ 1 lobe

*Necrotizing bronchopneumoniaandpneumatocelecan be caused byStaphylococcus aureusand are often preceded by aninfluenzainfection

Name the 2 described above.

A
  1. Lobar pneumonia
  2. Broncho pneumonia
18
Q

Describe miliary pneumonia and cryptogenic organizing pneumonia.

A

*Miliary pneumonia: multiple small infiltrations caused by hematogenous dissemination (e.g., oftuberculosis)

*Cryptogenic organizing pneumonia: characterized byinflammationof thebronchiolesand surrounding structures

19
Q

Describe Interstitial pneumonia.

A

*Characterized by a diffuse patchyinflammationthat mainly involves the alveolarinterstitialcells

*Bilateral multifocal opacities are classically found onchest x-ray

*Often has an indolent course (walking pneumonia)

20
Q

Lobar pneumonia is a specific form of pneumonia characterized by the involvement of an entire lobe of one lung.

The progression of lobar pneumonia typically goes through four stages, known as the four classic stages of pneumonia.

Describe the 4 stages of lobar pneumonia.

A

These stages were first described by Sir William Osler. Here’s an overview of each stage:

  1. Congestion (Stage 1):

Timeframe: 0-2 days after infection.

Pathological Changes: The affected lobe becomes congested with blood and the blood vessels dilate.

The alveoli start to fill with a serous fluid, white blood cells, and bacteria. This initial stage is characterized by vascular engorgement and edema.

Clinical Features: Patients may experience non-specific symptoms such as fever, malaise, and cough. Chest pain may be present.

  1. Red Hepatization (Stage 2):

Timeframe: 3-4 days after infection.

Pathological Changes: The lung becomes more solid as the red and white blood cells, bacteria, and fibrin accumulate in the alveoli. This gives the affected lobe a liver-like (hepatized) appearance.

Clinical Features: Symptoms intensify, with high fever, productive cough (often with rust-colored sputum), increased chest pain, and signs of consolidation on physical examination, such as dullness to percussion and bronchial breath sounds.

  1. Gray Hepatization (Stage 3)

Timeframe: 5-7 days after infection.

Pathological Changes: The red blood cells in the affected area undergo degeneration, resulting in a grayish appearance of the hepatized tissue.

The inflammatory exudate begins to break down.

Clinical Features: Fever may start to subside, and there may be a gradual resolution of symptoms.
However, cough and weakness may persist.

  1. Resolution (Stage 4):

Timeframe: Beyond 8 days after infection.

Pathological Changes: The inflammatory exudate is further broken down and cleared by macrophages.

The lung tissue gradually returns to normal, and the alveoli are restored to their normal state.

Clinical Features: Symptoms continue to improve, and the patient starts to recover. Resolution may take weeks, and complete recovery may require a longer period.

21
Q

Outline the causative agents for pneumonia in immunocompromised patients.

A

-Pneumocystis jirovecii pneumoniae
-Aspergillus fumigatus
-Histoplasma capsulatum
-Candida species
-CMV
-s.aureus

22
Q

Outline some causes of lobar consolidation.

A

-Lobar pneumonia
-Neoplasm
-Hemorrhage: contusion, infarction

23
Q

State the 2 main causative agents of pneumonia across all age groups.

A
  1. Staphylococcus pneumoniae
  2. Hemophilus influenza
24
Q

Compare the presentations of typical and atypical pneumonia.

A

Typical pneumonia; sudden onsetmalaise,fever, and a productivecough. Onauscultation,cracklesand bronchial breath sounds are audible.

-Characterized by asudden onset of symptoms caused by lobar infiltration.

-Productive cough with purulent sputum (yellow greenish)

-Fever, chills, malaise, Pleuritic chest pain

Clinical Signs
-Signs of consolidation (e.g., ↑ tactile fremitus, —
Dullness to percussion,↑ egophony, bronchialbreath sounds onauscultation)

Abnormal Auscultation (Egophony): In cases of lung consolidation, where there is a solidification of lung tissue (as seen in pneumonia), the sound transmission may be altered.

Instead of hearing the expected “E” sound, the examiner may hear a nasal or bleating quality, resembling the sound of a goat. This altered sound is termed “egophony.”

-Signs of infiltrates; crackles on auscultation

-Tachypnea andrespiratory distress

ATYPICAL PNEUMONIA
Atypical pneumonia; gradual onset unproductivecough,dyspnea, and extrapulmonary manifestations.

*Auscultationis usually unremarkable.

*Has anindolent course (slow onset), with less distinct classical symptoms (dry cough) and commonly manifests with extrapulmonary symptoms (fatigue, headaches, sore throat,myalgias, andmalaise)
often unremarkable findings onauscultationand percussion

25
Q

_________________Manifests as lobar pneumonia or bronchopneumonia.

_____________manifests as Interstitial pneumonia.

A

TYPICAL PNEUMONIA: Manifests as lobar pneumonia or bronchopneumonia

Atypical Pneumonia: Manifests as Interstitial pneumonia

26
Q

Describe the prognosis of pneumonia.

The mortality risk can be evaluated with theCURB-65 score.

Describe it.

A

PROGNOSIS

Confusion: 1
Urea >7 mmol/L
Respiratory Rate >30
Blood Pressure; Systolic <90mmHg
HAP= Hospital Acquired Pneumonia

Mortality increases with age.
Score 0:∼ 1%
Score 1–2:∼ 10%
Score 3:∼ 14%
Score 4:∼ 40%
HAPis associated with amortality rateof> 20%.

27
Q

Describe the PNEUMONIA: COMPLICATIONS.

Parapneumonic pleuritis

Parapneumonic effusion

Empyema

Lung abscess

ARDS

Respiratory Failure

Sepsis

A
  1. Parapneumonic Pleuritis:

Description: Inflammation of the pleura (the membrane surrounding the lungs) due to pneumonia. It occurs when the infection spreads to the pleural space.

Mechanism: Inflammatory response causes fluid accumulation in the pleural cavity, leading to pleuritic chest pain.

  1. Parapneumonic Effusion:

Description: Accumulation of fluid in the pleural space as a complication of pneumonia.

Mechanism: Inflammatory response results in increased fluid production, which may cause compression of the lung, leading to respiratory distress.

  1. Empyema:

Description: A more severe form of parapneumonic effusion where the fluid in the pleural space becomes infected with bacteria.

Mechanism: Bacterial invasion leads to pus formation in the pleural cavity, causing increased pressure and impaired lung function.

  1. Lung Abscess:

Description: Formation of a localized collection of pus within the lung tissue.

Mechanism: Inflammatory response and tissue necrosis result in the formation of a cavity filled with pus, often requiring drainage.

  1. Acute Respiratory Distress Syndrome (ARDS):

Description: Severe, life-threatening lung condition characterized by widespread inflammation and fluid leakage into the alveoli.

Mechanism: Infection-induced inflammation damages the lung’s delicate structure, leading to impaired gas exchange and severe respiratory distress.

  1. Respiratory Failure:

Description: Inability of the respiratory system to maintain adequate oxygen levels or eliminate carbon dioxide.

Mechanism: Severe pneumonia can overwhelm the respiratory capacity, leading to respiratory failure.

  1. Sepsis:
    Description: Systemic inflammatory response to infection affecting multiple organs.

Mechanism: Pneumonia can trigger a dysregulated immune response, leading to widespread inflammation and organ dysfunction characteristic of sepsis.

28
Q

Outline the preventative measures for pneumonia.

A

Pneumococcal Vaccination
Influenza Vaccination
Smoking cessation

29
Q

Describe Pneumonia in Immunocompromised Patients.

State the 5 major immunocompromised host groups.

A

Complex infection and inflammation of the lower respiratory tract, complicated by widespread multi-drug antibiotic resistance.

Carries a high mortality and morbidity rate.

The major immunocompromised host groups are those with:

*HIV/AIDS
*Solid organ and hematopoietic cell transplants
*Malignancy on chemotherapy or radiation therapy
*Primary immunodeficiencies and autoimmune diseases
*Acquired immunodeficiencies: asplenia, long-term steroid use

30
Q

Outline Common organisms for Pneumonia in Immunocompromised Patients.

A

Common organisms:

-TB and non-­TB mycobacteria, mainly Mycobacterium avium complex (MAC)

-Fungal: PJP, Aspergillus fumigatus, Histoplasma, Cryptococcus neoformans, Mucormycosis

-Viruses: ­Cytomegalovirus (CMV), herpes simplex virus (HSV) and varicella zoster virus (VZV)